73 related articles for article (PubMed ID: 17961420)
1. [Overexpression of heat shock protein 27 reduces mortality and attenuates cardiac dysfunction induced by doxorubicin in a transgenic mouse model].
Liu L; Zhang XJ; Qian B; Min XY; Cheng YL
Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Jul; 35(7):595-8. PubMed ID: 17961420
[TBL] [Abstract][Full Text] [Related]
2. [Heat shock protein 27 attenuated doxorubicin-induced myocardial damage by reducing cardiomyocyte apoptosis, mitochondria damage and protein carbonylation].
Liu L; Zhang XJ; Qian B; Min XY; Cheng YL
Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Nov; 36(11):1021-6. PubMed ID: 19102918
[TBL] [Abstract][Full Text] [Related]
3. Cardiac-specific expression of heat shock protein 27 attenuated endotoxin-induced cardiac dysfunction and mortality in mice through a PI3K/Akt-dependent mechanism.
You W; Min X; Zhang X; Qian B; Pang S; Ding Z; Li C; Gao X; Di R; Cheng Y; Liu L
Shock; 2009 Jul; 32(1):108-17. PubMed ID: 19106822
[TBL] [Abstract][Full Text] [Related]
4. Modulation of doxorubicin-induced cardiac dysfunction in dominant-negative p38α mitogen-activated protein kinase mice.
Thandavarayan RA; Watanabe K; Sari FR; Ma M; Lakshmanan AP; Giridharan VV; Gurusamy N; Nishida H; Konishi T; Zhang S; Muslin AJ; Kodama M; Aizawa Y
Free Radic Biol Med; 2010 Nov; 49(9):1422-31. PubMed ID: 20705132
[TBL] [Abstract][Full Text] [Related]
5. Over-expression of heat shock protein 27 attenuates doxorubicin-induced cardiac dysfunction in mice.
Liu L; Zhang X; Qian B; Min X; Gao X; Li C; Cheng Y; Huang J
Eur J Heart Fail; 2007 Aug; 9(8):762-9. PubMed ID: 17481944
[TBL] [Abstract][Full Text] [Related]
6. Modulation of doxorubicin-induced cardiac dysfunction in toll-like receptor-2-knockout mice.
Nozaki N; Shishido T; Takeishi Y; Kubota I
Circulation; 2004 Nov; 110(18):2869-74. PubMed ID: 15505089
[TBL] [Abstract][Full Text] [Related]
7. High-mobility group box 1-mediated heat shock protein beta 1 expression attenuates mitochondrial dysfunction and apoptosis.
Narumi T; Shishido T; Otaki Y; Kadowaki S; Honda Y; Funayama A; Honda S; Hasegawa H; Kinoshita D; Yokoyama M; Nishiyama S; Takahashi H; Arimoto T; Miyamoto T; Watanabe T; Tanaka A; Woo CH; Abe J; Takeishi Y; Kubota I
J Mol Cell Cardiol; 2015 May; 82():1-12. PubMed ID: 25736854
[TBL] [Abstract][Full Text] [Related]
8. Serine mutations in overexpressed Hsp27 abrogate the protection against doxorubicin-induced p53-dependent cardiac apoptosis in mice.
Kanagasabai R; Karthikeyan K; Zweier JL; Ilangovan G
Am J Physiol Heart Circ Physiol; 2021 Nov; 321(5):H963-H975. PubMed ID: 34477462
[TBL] [Abstract][Full Text] [Related]
9. MCP-1 induces cardioprotection against ischaemia/reperfusion injury: role of reactive oxygen species.
Morimoto H; Hirose M; Takahashi M; Kawaguchi M; Ise H; Kolattukudy PE; Yamada M; Ikeda U
Cardiovasc Res; 2008 Jun; 78(3):554-62. PubMed ID: 18267955
[TBL] [Abstract][Full Text] [Related]
10. Morphological and functional alterations in ventricular myocytes from male transgenic mice with hypertrophic cardiomyopathy.
Olsson MC; Palmer BM; Stauffer BL; Leinwand LA; Moore RL
Circ Res; 2004 Feb; 94(2):201-7. PubMed ID: 14670849
[TBL] [Abstract][Full Text] [Related]
11. Phosphodiesterase-5 inhibition with sildenafil attenuates cardiomyocyte apoptosis and left ventricular dysfunction in a chronic model of doxorubicin cardiotoxicity.
Fisher PW; Salloum F; Das A; Hyder H; Kukreja RC
Circulation; 2005 Apr; 111(13):1601-10. PubMed ID: 15811867
[TBL] [Abstract][Full Text] [Related]
12. Hsp70 regulates the doxorubicin-mediated heart failure in Hsp70-transgenic mice.
Naka K K; Vezyraki P; Kalaitzakis A; Zerikiotis S; Michalis L; Angelidis C
Cell Stress Chaperones; 2014 Nov; 19(6):853-64. PubMed ID: 24748476
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of glutathione peroxidase prevents left ventricular remodeling and failure after myocardial infarction in mice.
Shiomi T; Tsutsui H; Matsusaka H; Murakami K; Hayashidani S; Ikeuchi M; Wen J; Kubota T; Utsumi H; Takeshita A
Circulation; 2004 Feb; 109(4):544-9. PubMed ID: 14744974
[TBL] [Abstract][Full Text] [Related]
14. Transgenic alpha1A-adrenergic activation limits post-infarct ventricular remodeling and dysfunction and improves survival.
Du XJ; Gao XM; Kiriazis H; Moore XL; Ming Z; Su Y; Finch AM; Hannan RA; Dart AM; Graham RM
Cardiovasc Res; 2006 Sep; 71(4):735-43. PubMed ID: 16859660
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of mitochondrial peroxiredoxin-3 prevents left ventricular remodeling and failure after myocardial infarction in mice.
Matsushima S; Ide T; Yamato M; Matsusaka H; Hattori F; Ikeuchi M; Kubota T; Sunagawa K; Hasegawa Y; Kurihara T; Oikawa S; Kinugawa S; Tsutsui H
Circulation; 2006 Apr; 113(14):1779-86. PubMed ID: 16585391
[TBL] [Abstract][Full Text] [Related]
16. Protection against doxorubicin-induced myocardial dysfunction in mice by cardiac-specific expression of carboxyl terminus of hsp70-interacting protein.
Wang L; Zhang TP; Zhang Y; Bi HL; Guan XM; Wang HX; Wang X; Du J; Xia YL; Li HH
Sci Rep; 2016 Jun; 6():28399. PubMed ID: 27323684
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of wild-type heat shock protein 27 and a nonphosphorylatable heat shock protein 27 mutant protects against ischemia/reperfusion injury in a transgenic mouse model.
Hollander JM; Martin JL; Belke DD; Scott BT; Swanson E; Krishnamoorthy V; Dillmann WH
Circulation; 2004 Dec; 110(23):3544-52. PubMed ID: 15569832
[TBL] [Abstract][Full Text] [Related]
18. Low-intensity exercise training during doxorubicin treatment protects against cardiotoxicity.
Chicco AJ; Hydock DS; Schneider CM; Hayward R
J Appl Physiol (1985); 2006 Feb; 100(2):519-27. PubMed ID: 16210442
[TBL] [Abstract][Full Text] [Related]
19. Cytoprotective role of Phyllanthus urinaria L. and glutathione-S transferase Pi in doxorubicin-induced toxicity in H9c2 cells.
Chularojmontri L; Ihara Y; Muroi E; Goto S; Kondo T; Wattanapitayakul SK
J Med Assoc Thai; 2009 Jun; 92 Suppl 3():S43-51. PubMed ID: 19705546
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of endogenous Mst1 prevents apoptosis and cardiac dysfunction without affecting cardiac hypertrophy after myocardial infarction.
Odashima M; Usui S; Takagi H; Hong C; Liu J; Yokota M; Sadoshima J
Circ Res; 2007 May; 100(9):1344-52. PubMed ID: 17395874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
